2022 Legal Litigating Prima Facie Case 
Day on Torts
OCTOBER 3, 2022
M2021-00878-COA-R3-CV, 2022 WL 4490980 (Tenn. 28, 2022), plaintiff was a real estate professional involved in some capacity with Durham Farms, which was a large residential community. Having found that the TPPA applied, the Court moved on to considering whether plaintiff had shown a prima facie case for each element of his two claims.
Day on Torts
NOVEMBER 15, 2022
When a litigant has filed a motion to dismiss pursuant to the Tennessee Public Participation Act (TPPA), that motion should be analyzed under the provisions of the TPPA rather than under the traditional Tennessee Rule of Civil Procedure 12 analysis. E2021-01513-COA-R3-CV, 2022 WL 16559447 (Tenn. In Reiss v. quoting Tenn. Code Ann. §
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Patently O
MARCH 31, 2024
In a recent decision, the Federal Circuit vacated a judgment of invalidity and remanded for a new trial, holding that the district court’s jury instruction on objective indicia of nonobviousness constituted prejudicial legal error. The case, Inline Plastics Corp. 2022-1954 (Fed. Lacerta Group, LLC , No.
Patently O
NOVEMBER 29, 2023
Vidal (No 23-135): This case challenges the “ Fintiv rule” that restricts the initiation of inter partes review in cases where parallel district court litigation is pending. 23-315): This case questions the Federal Circuit’s interpretation of time limits for joining IPR partes. Traxcell Techs.
Conflict of Laws
JUNE 11, 2023
The Chinese Judgment recorded that: ‘[t]he defendant [Yin] failed to attend despite having been legally summoned to attend. On 22 October 2021, summary judgment was entered in favour of Wu by an Associate Justice of the Supreme Court: Wu v Yin (Supreme Court of Victoria, Efthrim AsJ, 22 October 2021); see Wu v Yin [2022] VSC 729, [5].
Patently O
APRIL 1, 2024
2022-1258 (Fed. The case involved Janson’s U.S. In the ensuing Hatch-Waxman litigation, Teva stipulated to infringement but challenged the patent on obviousness and indefiniteness grounds. Janssen Pharms., Teva Pharms. USA, Inc. , Following a bench trial Judge Cecchi (D.N.J.)
JonathanTurley
FEBRUARY 26, 2023
It did so in the Dobbs decision in 2022 ). That was not the case with the Dallas County case. If the groups split the litigation in the hopes of securing a more favorable court, it succeeded. The court of appeals decision, in my view, is wildly off-base with existing free speech doctrines and cases.
Expert insights. Personalized for you.
59 
Let's personalize your content